Statins: Have we found the Holy Grail?

14Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

In coronary artery disease, cardiovascular risk factors are the main targets for primary and secondary prevention. Statins prevent cardiovascular events in patients at risk. However, despite the proven efficacy and safety of statins, relevant side effects exist and should be considered when treating patients.

Cite

CITATION STYLE

APA

Jeger, R., & Dieterle, T. (2012). Statins: Have we found the Holy Grail? Swiss Medical Weekly. SMW supporting association. https://doi.org/10.4414/smw.2012.13515

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free